Related references
Note: Only part of the references are listed.An overview of lipidomic analysis in different human matrices of multiple sclerosis
Helena Beatriz Ferreira et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid
Ilaria Cicalini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Docosahexaenoic acid (22:6n-3) Ameliorated the Onset and Severity of Experimental Autoimmune Encephalomyelitis in Mice
Yuriko Adkins et al.
LIPIDS (2019)
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
Stephanie Herman et al.
CELLS (2019)
Altered Cerebrospinal Fluid Concentrations of Hydrophobic and Hydrophilic Compounds in Early Stages of Multiple Sclerosis-Metabolic Profile Analyses
A. Podlecka-Pietowska et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2019)
Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury
Zhongyang Xie et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Identification of Altered Metabolic Pathways during Disease Progression in EAE Mice via Metabolomics and Lipidomics
Gakyung Lee et al.
NEUROSCIENCE (2019)
Metabolome-based signature of disease pathology in MS
S. L. Andersen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Imaging Mass Spectrometry: A New Tool to Assess Molecular Underpinnings of Neurodegeneration
Kevin Chen et al.
METABOLITES (2019)
Multiple sclerosis has a distinct lipid signature in plasma and cerebrospinal fluid
Enedina Maria Lobato de Oliveira et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2019)
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
L. Nogueras et al.
SCIENTIFIC REPORTS (2019)
Oleic acid is a potent inducer for lipid droplet accumulation through its esterification to glycerol by diacylglycerol acyltransferase in primary cortical astrocytes
Shingo Nakajima et al.
BRAIN RESEARCH (2019)
Correlated Heterospectral Lipidomics for Biomolecular Profiling of Remyelination in Multiple Sclerosis
Mads S. Bergholt et al.
ACS CENTRAL SCIENCE (2018)
Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
Daniel Stoessel et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2018)
Phosphatidylcholine 36:1 concentration decreasesalong with demyelination in the cuprizone animal model and in post-mortem multiple sclerosis brain tissue
Marc-Olivier Trepanier et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Progressive Forms of Multiple Sclerosis Distinct Entity or Age-Dependent Phenomena
Burcu Zeydan et al.
NEUROLOGIC CLINICS (2018)
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Jasmine Chong et al.
NUCLEIC ACIDS RESEARCH (2018)
Expanding lipidome coverage using MS/MS-aided untargeted data-independent RP-UPLC-TOF-MSE acquisition
Panagiotis A. Vorkas
BIOANALYSIS (2018)
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients
Damiana Pieragostino et al.
SCIENTIFIC REPORTS (2018)
Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy
Joern Loetsch et al.
SCIENTIFIC REPORTS (2018)
Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
Stephanie Herman et al.
THERANOSTICS (2018)
Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
Chai K. Lim et al.
SCIENTIFIC REPORTS (2017)
The use of vibrational spectroscopy to study the pathogenesis multiple sclerosis and other neurological conditions
Ines R. Ramos et al.
APPLIED SPECTROSCOPY REVIEWS (2017)
Multiple Sclerosis: Immunopathology and Treatment Update
Narges Dargahi et al.
BRAIN SCIENCES (2017)
Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms
Shahin Aeinehband et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Protocol for quality control in metabolic profiling of biological fluids by U(H)PLC-MS
Helen G. Gika et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a neuroprotective role
Rachel Waller et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica
Teklab Gebregiworgis et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Metabolomics in multiple sclerosis
Pavan Bhargava et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
The relationship of age with the clinical phenotype in multiple sclerosis
A. Scalfari et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Extracellular vesicles round off communication in the nervous system
Vivian Budnik et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Multiple sclerosis prevalence in the United States commercially insured population
Piyameth Dilokthornsakul et al.
NEUROLOGY (2016)
Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine
Piero Del Boccio et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
Metabolomics in multiple sclerosis
Pavan Bhargava et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
The relationship of age with the clinical phenotype in multiple sclerosis
A. Scalfari et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes
Simon Zhornitsky et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Pentadecanoic and Heptadecanoic Acids: Multifaceted Odd-Chain Fatty Acids
Maria Pfeuffer et al.
ADVANCES IN NUTRITION (2016)
Metabolism and functions of lipids in myelin
Sebastian Schmitt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study
Vijitha K. Senanayake et al.
BMC NEUROLOGY (2015)
A lipidomic approach to the study of human CD4+ T lymphocytes in multiple sclerosis
Daniele Vergara et al.
BMC NEUROSCIENCE (2015)
Hyperinsulinemia in newly diagnosed patients with multiple sclerosis
Adela Penesova et al.
METABOLIC BRAIN DISEASE (2015)
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis
Damiana Pieragostino et al.
MOLECULAR BIOSYSTEMS (2015)
A Review of Odd-Chain Fatty Acid Metabolism and the Role of Pentadecanoic Acid (C15:0) and Heptadecanoic Acid (C17:0) in Health and Disease
Benjamin Jenkins et al.
MOLECULES (2015)
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics
Oscar G. Vidaurre et al.
BRAIN (2014)
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis
Alex M. Dickens et al.
NEUROLOGY (2014)
Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation
Dominik Froehlich et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis
Robert K. McNamara et al.
PSYCHIATRY RESEARCH (2014)
Diffusely Abnormal White Matter in Multiple Sclerosis: Further Histologic Studies Provide Evidence for a Primary Lipid Abnormality With Neurodegeneration
Cornelia Laule et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine
Asa M. Wheelock et al.
MOLECULAR BIOSYSTEMS (2013)
Endothelial TWIK-related potassium channel-1 (TREK 1) regulates immune-cell trafficking into the CNS
Stefan Bittner et al.
NATURE MEDICINE (2013)
LipidBlast in silico tandem mass spectrometry database for lipid identification
Tobias Kind et al.
NATURE METHODS (2013)
Grey matter lesions in MS From histology to clinical implications
Massimiliano Calabrese et al.
PRION (2013)
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Jack Antel et al.
ACTA NEUROPATHOLOGICA (2012)
Building Multivariate Systems Biology Models
Gemma M. Kirwan et al.
ANALYTICAL CHEMISTRY (2012)
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
Sung R. Choi et al.
BRAIN (2012)
Progressive multiple sclerosis: pathology and pathogenesis
Hans Lassmann et al.
NATURE REVIEWS NEUROLOGY (2012)
A QC approach to the determination of day-to-day reproducibility and robustness of LC-MS methods for global metabolite profiling in metabonomics/metabolomics
Helen G. Gika et al.
BIOANALYSIS (2012)
The neuropathological basis of clinical progression in multiple sclerosis
Richard Reynolds et al.
ACTA NEUROPATHOLOGICA (2011)
Quantification of plasma phospholipids by ultra performance liquid chromatography tandem mass spectrometry
Yannick Rabagny et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
MASS SPECTROMETRY-BASED HOLISTIC ANALYTICAL APPROACHES FOR METABOLITE PROFILING IN SYSTEMS BIOLOGY STUDIES
Georgios Theodoridis et al.
MASS SPECTROMETRY REVIEWS (2011)
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Ivana Nikic et al.
NATURE MEDICINE (2011)
Paradoxical Increase in TAG and DAG Content Parallel the Insulin Sensitizing Effect of Unilateral DGAT1 Overexpression in Rat Skeletal Muscle
Silvie Timmers et al.
PLOS ONE (2011)
MULTIPLE SCLEROSIS IS NOT A DISEASE OF THE IMMUNE SYSTEM
Angelique P. Corthals
QUARTERLY REVIEW OF BIOLOGY (2011)
Evidence for a two-stage disability progression in multiple sclerosis
Emmanuelle Leray et al.
BRAIN (2010)
Spingolipids in Multiple Sclerosis
Silke Walter et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Lipidomics reveals a remarkable diversity of lipids in human plasma
Oswald Quehenberger et al.
JOURNAL OF LIPID RESEARCH (2010)
Lipid Mediators in the Neural Cell Nucleus: Their Metabolism, Signaling, and Association with Neurological Disorders
Akhlaq A. Farooqui
NEUROSCIENTIST (2009)
HMDB: a knowledgebase for the human metabolome
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2009)
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis
David Wheeler et al.
BRAIN (2008)
LIPID MAPS online tools for lipid research
Eoin Fahy et al.
NUCLEIC ACIDS RESEARCH (2007)
Chemometrics in metabonomics
Johan Trygg et al.
JOURNAL OF PROTEOME RESEARCH (2007)
The immunosuppressant drug FTY720 inhibits cytosohc phospholipase A2 independently of sphingosine-1-phosphate receptors
Shawn G. Payne et al.
BLOOD (2007)
UPLC/MSE; a new approach for generating molecular fragment information for biomarker structure elucidation
Robert S. Plumb et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
Phospholipase A(2)-generated lipid mediators in the brain: The good, the bad, and the ugly
Akhlaq A. Farooqui et al.
NEUROSCIENTIST (2006)
METLIN - A metabolite mass spectral database
CA Smith et al.
THERAPEUTIC DRUG MONITORING (2005)
Relapses and progression of disability in multiple sclerosis.
C Confavreux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
